TRMA is caused by homozygous mutations in the SLC19A2 gene [4], which encodes a high-affinity thiamine transporter 1 protein (THTR-1) [5,6], located on chromosome 1q23.3. The gene discussed is SLC19A2; the disease is thiamine-responsive megaloblastic anemia syndrome.